Effectiveness of Sepharose-bound trypsin versus liquid-phase trypsin plus benzamidine for activation of inactive renin in human plasma

A. Morganti, C. Sala, L. Turolo, F. Auxilia, L. Cianci, M. Checchini, A. Zanchetti

Research output: Contribution to journalArticle

2 Citations (Scopus)

Abstract

We compared the effectiveness of two techniques involving the use of the enzyme trypsin to activate inactive renin in human plasma. Both these methods were developed to optimize activation with trypsin by preventing the possible destruction of activated renin by trypsin itself. In one method, an antitryptic agent such as benzamidine is added to plasma, concomitantly with trypsin (liquid phase). In the other a low concentration of Sepharose-bound (immobilized) trypsin is used. In six plasma samples we have found that trypsin (1.5 mg/ml) activation, with or without benzamidine (0.8 mg/ml), yielded similar values of activated renin (11.0 ± 2.7 vs 11.3 ± 2.3 ng/ml/hr). However, the addition of immobilized trypsin to pool plasma pretreated with trypsin plus benzamidine caused a further increase in plasma renin activity (PRA); in contrast, the addition of trypsin and benzamidine to pool plasma pretreated with immobilized trypsin caused a decrease in PRA. In 17 plasma samples from patients with essential hypertension we found that the inactive renin values were always higher after treatment with immobilized trypsin than with trypsin plus benzamidine (9.0 ± 0.7 vs. 6.1 ± 0.5 ng/ml/hr, P

Original languageEnglish
Pages (from-to)13-18
Number of pages6
JournalThe Journal of Laboratory and Clinical Medicine
Volume109
Issue number1
Publication statusPublished - 1987

Fingerprint

Renin
Sepharose
Trypsin
benzamidine

ASJC Scopus subject areas

  • Medicine(all)
  • Pathology and Forensic Medicine

Cite this

Effectiveness of Sepharose-bound trypsin versus liquid-phase trypsin plus benzamidine for activation of inactive renin in human plasma. / Morganti, A.; Sala, C.; Turolo, L.; Auxilia, F.; Cianci, L.; Checchini, M.; Zanchetti, A.

In: The Journal of Laboratory and Clinical Medicine, Vol. 109, No. 1, 1987, p. 13-18.

Research output: Contribution to journalArticle

Morganti, A, Sala, C, Turolo, L, Auxilia, F, Cianci, L, Checchini, M & Zanchetti, A 1987, 'Effectiveness of Sepharose-bound trypsin versus liquid-phase trypsin plus benzamidine for activation of inactive renin in human plasma', The Journal of Laboratory and Clinical Medicine, vol. 109, no. 1, pp. 13-18.
Morganti, A. ; Sala, C. ; Turolo, L. ; Auxilia, F. ; Cianci, L. ; Checchini, M. ; Zanchetti, A. / Effectiveness of Sepharose-bound trypsin versus liquid-phase trypsin plus benzamidine for activation of inactive renin in human plasma. In: The Journal of Laboratory and Clinical Medicine. 1987 ; Vol. 109, No. 1. pp. 13-18.
@article{b50cb316c30a4f41bdcfd360901f97a1,
title = "Effectiveness of Sepharose-bound trypsin versus liquid-phase trypsin plus benzamidine for activation of inactive renin in human plasma",
abstract = "We compared the effectiveness of two techniques involving the use of the enzyme trypsin to activate inactive renin in human plasma. Both these methods were developed to optimize activation with trypsin by preventing the possible destruction of activated renin by trypsin itself. In one method, an antitryptic agent such as benzamidine is added to plasma, concomitantly with trypsin (liquid phase). In the other a low concentration of Sepharose-bound (immobilized) trypsin is used. In six plasma samples we have found that trypsin (1.5 mg/ml) activation, with or without benzamidine (0.8 mg/ml), yielded similar values of activated renin (11.0 ± 2.7 vs 11.3 ± 2.3 ng/ml/hr). However, the addition of immobilized trypsin to pool plasma pretreated with trypsin plus benzamidine caused a further increase in plasma renin activity (PRA); in contrast, the addition of trypsin and benzamidine to pool plasma pretreated with immobilized trypsin caused a decrease in PRA. In 17 plasma samples from patients with essential hypertension we found that the inactive renin values were always higher after treatment with immobilized trypsin than with trypsin plus benzamidine (9.0 ± 0.7 vs. 6.1 ± 0.5 ng/ml/hr, P",
author = "A. Morganti and C. Sala and L. Turolo and F. Auxilia and L. Cianci and M. Checchini and A. Zanchetti",
year = "1987",
language = "English",
volume = "109",
pages = "13--18",
journal = "Journal of Laboratory and Clinical Medicine",
issn = "0022-2143",
publisher = "Mosby Inc.",
number = "1",

}

TY - JOUR

T1 - Effectiveness of Sepharose-bound trypsin versus liquid-phase trypsin plus benzamidine for activation of inactive renin in human plasma

AU - Morganti, A.

AU - Sala, C.

AU - Turolo, L.

AU - Auxilia, F.

AU - Cianci, L.

AU - Checchini, M.

AU - Zanchetti, A.

PY - 1987

Y1 - 1987

N2 - We compared the effectiveness of two techniques involving the use of the enzyme trypsin to activate inactive renin in human plasma. Both these methods were developed to optimize activation with trypsin by preventing the possible destruction of activated renin by trypsin itself. In one method, an antitryptic agent such as benzamidine is added to plasma, concomitantly with trypsin (liquid phase). In the other a low concentration of Sepharose-bound (immobilized) trypsin is used. In six plasma samples we have found that trypsin (1.5 mg/ml) activation, with or without benzamidine (0.8 mg/ml), yielded similar values of activated renin (11.0 ± 2.7 vs 11.3 ± 2.3 ng/ml/hr). However, the addition of immobilized trypsin to pool plasma pretreated with trypsin plus benzamidine caused a further increase in plasma renin activity (PRA); in contrast, the addition of trypsin and benzamidine to pool plasma pretreated with immobilized trypsin caused a decrease in PRA. In 17 plasma samples from patients with essential hypertension we found that the inactive renin values were always higher after treatment with immobilized trypsin than with trypsin plus benzamidine (9.0 ± 0.7 vs. 6.1 ± 0.5 ng/ml/hr, P

AB - We compared the effectiveness of two techniques involving the use of the enzyme trypsin to activate inactive renin in human plasma. Both these methods were developed to optimize activation with trypsin by preventing the possible destruction of activated renin by trypsin itself. In one method, an antitryptic agent such as benzamidine is added to plasma, concomitantly with trypsin (liquid phase). In the other a low concentration of Sepharose-bound (immobilized) trypsin is used. In six plasma samples we have found that trypsin (1.5 mg/ml) activation, with or without benzamidine (0.8 mg/ml), yielded similar values of activated renin (11.0 ± 2.7 vs 11.3 ± 2.3 ng/ml/hr). However, the addition of immobilized trypsin to pool plasma pretreated with trypsin plus benzamidine caused a further increase in plasma renin activity (PRA); in contrast, the addition of trypsin and benzamidine to pool plasma pretreated with immobilized trypsin caused a decrease in PRA. In 17 plasma samples from patients with essential hypertension we found that the inactive renin values were always higher after treatment with immobilized trypsin than with trypsin plus benzamidine (9.0 ± 0.7 vs. 6.1 ± 0.5 ng/ml/hr, P

UR - http://www.scopus.com/inward/record.url?scp=0023073517&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0023073517&partnerID=8YFLogxK

M3 - Article

VL - 109

SP - 13

EP - 18

JO - Journal of Laboratory and Clinical Medicine

JF - Journal of Laboratory and Clinical Medicine

SN - 0022-2143

IS - 1

ER -